Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Income (Loss) from Operations
QFR104385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
24,580.00
Year-over-Year Change
-19.11%
Date Range
10/1/2000 - 1/1/2025
Summary
This trend tracks the operational income of U.S. pharmaceutical and medicine corporations on a quarterly basis. It provides critical insights into the financial performance and health of a key sector in the American healthcare and biotechnology industries.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The metric represents the net earnings generated from core business operations before accounting for interest and taxes in the pharmaceutical sector. Economists and investors use this indicator to assess the sector's profitability, operational efficiency, and potential for future growth and investment.
Methodology
Data is collected through comprehensive quarterly financial reports submitted by pharmaceutical corporations to regulatory agencies, then aggregated and analyzed by the U.S. Federal Reserve.
Historical Context
This trend is used by policymakers, investors, and economic analysts to understand sector-specific economic performance, potential research and development investments, and broader healthcare industry dynamics.
Key Facts
- Provides quarterly snapshot of pharmaceutical corporate operational income
- Reflects financial health of a critical healthcare and innovation sector
- Offers insights into potential future research and development investments
FAQs
Q: What does this economic indicator measure?
A: It measures the operational income of U.S. pharmaceutical and medicine corporations before interest and taxes on a quarterly basis.
Q: Why is this trend important for investors?
A: It provides a direct view of sector profitability and potential for future growth, helping investors make informed decisions about healthcare and biotech investments.
Q: How frequently is this data updated?
A: The data is updated quarterly, providing a current and dynamic view of the pharmaceutical sector's financial performance.
Q: How do policymakers use this information?
A: Policymakers analyze this trend to understand sector dynamics, potential economic impacts, and to inform healthcare and innovation policy decisions.
Q: What are the limitations of this indicator?
A: While valuable, the indicator only represents operational income and does not capture all aspects of corporate financial health or future potential.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: All Durable Manufacturing: Other Direct Credits (Charges) to Retained Earnings (Net)
QFRD122DURUSNO
Quarterly Financial Report: U.S. Corporations: All Other Information: Net Sales, Receipts, and Operating Revenues
QFR101519USNO
Quarterly Financial Report: U.S. Corporations: Furniture and Related Products: All Other Nonoperating Income (Expense)
QFRD110337USNO
Chicago Fed National Financial Conditions Leverage Subindex
NFCILEVERAGE
Quarterly Financial Report: U.S. Corporations: Management and Technical Consulting Services: Trade Accounts and Trade Notes Payable
QFR306546USNO
Quarterly Financial Report: U.S. Corporations: Plastics and Rubber Products: All Other Operating Costs and Expenses
QFR103326USNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Income (Loss) from Operations [QFR104385USNO], retrieved from FRED.
Last Checked: 8/1/2025